Immunome, Inc.
Clinical trials sponsored by Immunome, Inc., explained in plain language.
-
Liver function and drug safety: new study on varegacestat
Knowledge-focused CompletedThis study looked at how the drug varegacestat moves through the body in people with liver problems compared to healthy people. About 35 adults took a single dose, and researchers measured drug levels and side effects. The goal was to understand if liver impairment changes how th…
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Healthy men swallow radioactive drug to track its journey through the body
Knowledge-focused CompletedThis completed Phase 1 study gave six healthy men a single oral dose of varegacestat containing a tiny radioactive tracer. Researchers measured how much of the drug appeared in blood, urine, and feces to understand how the body absorbs, breaks down, and eliminates it. The study d…
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Heart safety check for experimental drug varegacestat
Knowledge-focused CompletedThis completed phase 1 study tested whether a single dose of varegacestat changes heart rhythm in 32 healthy adults. Participants received varegacestat, a placebo, and a control drug (moxifloxacin) in random order. The main goal was to measure any effects on the heart's electrica…
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC